Tracleer and Carvedilol drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Tracleer (bosentan) and Carvedilol (carvedilol). Common drug interactions include diarrhoea among females and dyspnoea among males.
The phase IV clinical study analyzes what interactions people have when they take Tracleer and Carvedilol. It is created by eHealthMe based on reports of 258 people who take the same drugs from the FDA, and is updated regularly.
What is Tracleer?
Tracleer has active ingredients of bosentan. It is often used in primary pulmonary hypertension. eHealthMe is studying from 55,125 Tracleer users. Check the latest studies of Tracleer.
What is Carvedilol?
Carvedilol has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 112,649 Carvedilol users. Check the latest studies of Carvedilol.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
258 people who take Tracleer and Carvedilol together, and have interactions are studied.

What are the common drug interactions of Tracleer and Carvedilol, by gender? *
What are the common drug interactions of Tracleer and Carvedilol, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Tracleer and Carvedilol?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Tracleer (55,125 reports)
- Carvedilol (112,649 reports)
Browse all drug interactions of Tracleer and Carvedilol:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tracleer:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Carvedilol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tracleer and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Carvedilol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
- Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
- Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
- Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on bosentan and carvedilol (the active ingredients of Tracleer and Carvedilol, respectively), and Tracleer and Carvedilol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Paxil Cr cause Vertigo Aggravated? - 4 seconds ago
- Could Oxytrol cause Micturition Urgency? - 31 seconds ago
- Could Colace cause Escherichia Sepsis? - 31 seconds ago
- Could Eylea cause Nervousness? - 34 seconds ago
- Drug interactions of Provera and Atrovent - 41 seconds ago
- Could Omeprazole cause Electroencephalogram Abnormal? - 46 seconds ago
- Could Omnipaque 140 cause Fibrosis? - a minute ago
- Could Pantoprazole cause Anal Injury? - a minute ago
- Could Ibuprofen cause Locked-In Syndrome? - a minute ago
- Could Ofloxacin cause Acute Myeloid Leukaemia Aggravated? - a minute ago